Drugs / BIBW 2948 BS
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT02216461 | Jan → Apr 2006 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02214901 | Mar → Jul 2005 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00726479 | Aug → Sep 2008 | chronic bronchitis | Boehringer Ingelheim | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BIBW 2948 BS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02216461 ↗ |
| Route | Inhaled | “BIBW 2948 BS (Inhalation Powder, Hard Capsule for HandiHaler®)” NCT00726479 ↗ |